Evidence map›Paper›PMID 22772151›Full record

ArticleEuropean radiology2013

Combined PET/CT-perfusion in patients with head and neck cancers.

Patrick Veit-Haibach, Daniel Schmid, Klaus Strobel, Jan D Soyka, Niklaus G Schaefer, Stephan K Haerle, Gerhard Huber, Gabriele Studer, Burkhardt Seifert, Thomas F Hany

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Patrick Veit-HaibachDepartment of Radiology, Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland. patrick.veit-haibach@usz.ch
Daniel Schmid
Klaus Strobel
Jan D Soyka
Niklaus G Schaefer
Stephan K Haerle
Gerhard Huber
Gabriele Studer
Burkhardt Seifert
Thomas F Hany
University Hospital of Zurich · CHInstitute of Social and Preventive Medicine · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesComputed tomography perfusion (CTP) can provide information about angiogenesis and blood-flow characteristics in tumours. [18F]Fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) is one of the major oncological imaging techniques which provides information about viability of the tumour cell and partly also about its aggressiveness. The aim of the study was to investigate the relationship between FDG and CTP data in patients with head and neck cancers. MATERIALS AND

methodsForty-one patients with a clinically suspected head and neck cancer were prospectively included. All patients underwent a combined PET/CT with an integrated CTP examination in the area of the head and neck tumour. CTP data (BF, BV and MTT) and PET data (SUVmax, SUVmean, TLG, PETvol) were compared between tumours and (1) healthy contralateral tissue, (2) inflammatory lesions, (3) metastatic lymph nodes, and CTP data and PET data were correlated in tumours.

resultsThirty-five patients had a head and neck cancer. All CTP data were statistically different between tumours, inflammatory lesions, healthy tissue and metastatic lymph nodes; PET/CT data were in part significantly different. CTP and PET parameters were not significantly correlated.

conclusionCTP and PET parameters were not significantly correlated; thus, the additional CTP values provide additional insights into tumour behaviour and their glycolytic status.

Indexed as

Multimodal ImagingPositron-Emission TomographyTomography, X-Ray ComputedAdultAgedBiopsyContrast MediaDiatrizoate MeglumineFemaleFluorodeoxyglucose F18Head and Neck NeoplasmsHumansIohexolLymphatic MetastasisMaleMiddle AgedContrast MediaDiatrizoate MeglumineFluorodeoxyglucose F18IohexoliopromideRadiopharmaceuticals

Identifiers

PMID22772151
OpenAlexW2030153985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.